Location
Headquarters: San Diego, California, United States, North America
Region: California
Country: US
Continent: North America
About
Dexcom is a global medical device company specializing in continuous glucose monitoring (CGM) technology for diabetes management. It develops and markets CGM systems that provide real-time glucose readings and data to phones or receivers, enabling users to monitor glucose levels and make informed health decisions. The company has a long history in glucose biosensing and supports an ecosystem of connected partners, with products like Dexcom G7 and Stelo Glucose Biosensor, and operates worldwide from its base in San Diego, California. Since its founding in 1999, Dexcom has focused on improving diabetes care by delivering accurate, non-invasive or minimally invasive glucose monitoring solutions.
Dexcom is a medical device company specializing in continuous glucose monitoring systems for diabetes management. Its products provide real-time glucose data to users and healthcare providers to support informed health decisions. The company develops and markets biosensors and related software platforms globally.
DexCom, Inc.
1999
for_profit
active
Industries
Primary Industry: Manufacturing
Categories
Funding & Financials
Public Company
1100000000
over-1b
ipo
NASDAQ:DXCM
nasdaq
Investors
Founders
John Burd
Lauren G. Otsuki
Scott Glenn
Leadership
David D Smith — Senior Staff Data Scientist
Paolo la'O — Country Head, International Business Operations
Stephen Patek — Principal Algorithm Engineer
Ivan Lai — Senior Director, Global Contract Manufacturing
Groff Bittner — Sr. Manager Engineering - Software Sustaining
John Loughlin — Director of Software Engineering
Alan Schachtely — Senior Director, Software Engineering
Steven R. Altman — board_member
Glen David Nelson — board_member
Technology Stack
Products
Dexcom G7 CGM System: A continuous glucose monitoring system providing real-time glucose readings for people with diabetes aged 2 and older, designed to support insulin users and those at risk of hypoglycemia.
Dexcom G6 CGM System: A continuous glucose monitoring system that provides real-time glucose data without fingerstick calibration, intended for people with diabetes aged 2 and older.
Stelo Glucose Biosensor System: An over-the-counter integrated continuous glucose monitor for adults 18 and older not on insulin, providing personal glucose insights to support lifestyle and behavior modifications.
Dexcom Clarity: A cloud-based reporting system that collects and analyzes glucose data from Dexcom CGM devices to help users and healthcare providers track glucose trends over time.
Dexcom Share and Follow: A data sharing service that allows users to share real-time glucose readings with up to 10 followers for remote monitoring and support.
Funding rounds
Post Ipo Debt · $1B · (2023-05-02)
Post Ipo Debt · (2020-05-12)
Post Ipo Equity · $750M · (2018-11-01)